Eyenovia (EYEN) entered into an amendment to its outstanding senior secured convertible debt due November 1, 2025. The Amendment defers the ...

Eyenovia, Inc., an ophthalmic technology company, announced an amendment to its senior secured convertible debt due November 1, 2025, which delays monthly interest and amortization payments from ...

Any forward-looking statements speak only as of the date on which they are made, and except as may be required under applicable securities laws, Eyenovia does not undertake any obligation to update ...

Eyenovia regains Nasdaq compliance, boosting investor confidence after a reverse stock split helped meet listing requirements. Shares surge 22.5%, driven by optimism around the company's ...

Eyenovia announces progress on its user-filled Optejet eye drop dispenser, aiming for U.S. regulatory approval in late 2025. Eyenovia, Inc. has made significant advancements in the development of ...

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company"), an ophthalmic technology company focused on completing development of its proprietary ...

Rigorous testing has resulted in observations of the Optejet’s durable base unit performing over 30,000 sprays, and 98% of ...

Eyenovia, Inc. (NASDAQ:EYEN – Free Report) – Equities researchers at HC Wainwright boosted their FY2025 earnings per share (EPS) estimates for shares of Eyenovia in a note issued to investors ...

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company"), an ophthalmic technology company focused on completing development of its proprietary ...

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its ...